J P Morgan Chase & Co set a €100.00 ($119.05) price objective on Merck KGaA (FRA:MRK) in a research report report published on Friday morning. The firm currently has a neutral rating on the healthcare company’s stock.

Several other equities analysts also recently weighed in on the company. Warburg Research set a €116.00 ($138.10) target price on Merck KGaA and gave the company a neutral rating in a research report on Friday, July 7th. Nord/LB reissued a neutral rating on shares of Merck KGaA in a report on Wednesday, June 28th. equinet AG set a €112.00 ($133.33) price target on Merck KGaA and gave the company a neutral rating in a report on Monday, June 26th. Societe Generale set a €103.00 ($122.62) price target on Merck KGaA and gave the company a neutral rating in a report on Tuesday, September 5th. Finally, Goldman Sachs Group, Inc. (The) set a €105.00 ($125.00) price target on Merck KGaA and gave the company a neutral rating in a report on Wednesday, September 6th. Thirteen research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company’s stock. Merck KGaA currently has an average rating of Hold and an average price target of €109.61 ($130.49).

Shares of Merck KGaA (MRK) traded down 3.24% during trading on Friday, reaching €94.60. The company’s stock had a trading volume of 7,849 shares. Merck KGaA has a 12-month low of €89.00 and a 12-month high of €115.00. The company has a 50 day moving average of €93.46 and a 200 day moving average of €102.32. The company has a market cap of €41.13 billion and a PE ratio of 24.66.

WARNING: “Merck KGaA (MRK) Given a €100.00 Price Target by J P Morgan Chase & Co Analysts” was published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another publication, it was stolen and reposted in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2017/09/30/merck-kgaa-mrk-given-a-100-00-price-target-by-j-p-morgan-chase-co-analysts.html.

Merck KGaA Company Profile

.

Analyst Recommendations for Merck KGaA (FRA:MRK)

Receive News & Stock Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related stocks with our FREE daily email newsletter.